During the past decade, Carle Cancer Center conducted 307 clinical trials. In the 10-year time frame, 307 clinical trials started and 236 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 144 clinical trials started and 111 clinical trials were completed. i.e. 77.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carle Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 186 trials, followed by "National Cancer Institute (NCI)" with 184 trials sponsored, "SWOG Cancer Research Network" with 72 trials sponsored, "Eastern Cooperative Oncology Group" with 69 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 69 trials sponsored. Other sponsors include 202 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carle Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 508 trials as a collaborator, "NRG Oncology" with 47 trials as a collaborator, "Eastern Cooperative Oncology Group" with 34 trials as a collaborator, "Cancer and Leukemia Group B" with 26 trials as a collaborator and "SWOG Cancer Research Network" with 26 trials as a collaborator. Other collaborators include 184 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Carle Cancer Center" are "Breast Cancer" (76 trials), "Lung Cancer" (45 trials), "Prostate Cancer" (29 trials), "Colorectal Cancer" (27 trials) and "Lymphoma" (26 trials). Many other conditions were trialed in "Carle Cancer Center" in a lesser frequency.

Most popular intervention types in "Carle Cancer Center" are "Drug" (598 trials), "Other" (311 trials), "Biological" (231 trials), "Procedure" (151 trials) and "Radiation" (137 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (112 trials), "Quality-of-Life Assessment" (109 trials), "Questionnaire Administration" (74 trials), "Computed Tomography" (53 trials) and "placebo" (52 trials). Other intervention names were less common.

The vast majority of trials in "Carle Cancer Center" are 568 trials for "All" genders, 144 trials for "Female" genders and 42 trials for "Male" genders.

Currently, there are NaN active trials in "Carle Cancer Center". 1 are not yet recruiting, 131 are recruiting, 175 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 381 completed trials in Carle Cancer Center, 8 suspended trials, and 46 terminated clinical trials to date.

Out of the total trials that were conducted in Carle Cancer Center, 24 "Phase 1" clinical trials were conducted, 368 "Phase 2" clinical trials and 348 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 28 trials that are defined as “Not Applicable".